FDA Inspection
Coloplast CorpColoplast Corp – FDA Inspection, Apr 11, 2024
Record Details
This FDA Inspection record concerns Coloplast Corp, with an inspection on April 11, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · cefcac12-deae-4e04-b1da-3cfa19f02e93
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1236807
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.142(b)Storage under appropriate conditions
- 21 CFR 211.113(a)Procedures for non-sterile drug products
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Coloplast Corp
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 6, 2015 | NAI | Center for Food Safety and Applied Nutrition | Colors and Cosmetics Technology |
| July 13, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 26, 2010 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Coloplast Corp
- FDA Inspection 921891 - 2015-04-06
- FDA Inspection 791129 - 2012-07-13
- FDA Inspection 653661 - 2010-03-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.